Trademarkia Logo

Canada

C$
BIOSIMILARS LOGO
REGISTERED

on 17 Jun 2019

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

HOSPIRA INC.

275 North Field DriveLake Forest, IL 60045

US

Serial Number

1806713 filed on 27th Oct 2016

Registration Number

TMA1026004 registered on 17th Jun 2019

Registration expiry Date

17th Jun 2029

Correspondent Address

MBM INTELLECTUAL PROPERTY AGENCY

275 SLATER STREET14TH FLOOROTTAWA

ONTARIO

CA

K1P5H9

BIOSIMILARS LOGO

Trademark usage description

pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, menopausal, autoimmune, ophthalmological, respiratory and urologica Read More

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, menopausal, autoimmune, ophthalmological, respiratory and urological diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use; Pharmaceutical preparations for the treatment of central nervous system, endocrine, genetic, immunological, infectious, inflammatory, metabolic, musculoskeletal, neurological, psychiatric, urogenital and viral diseases and disorders, namely antibiotics, anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectable pharmaceutical contraceptives, pharmaceutical preparations for the treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, pharmaceutical preparations for the treatment of cranial and facial nerve disorders, tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders, pharmaceutical preparations for the treatment of neuromuscular and neurological diseases and disorders, namely brain, central nervous system, muscle, ocular motility and spinal cord infections, injuries and diseases, and seizure disorders, pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, pelvic, urological and reproductive system diseases, disorders and infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence, pharmaceutical preparations for the prevention and treatment of smoking habits and addictions, pharmaceutical preparations for the treatment of renal disease and disorders, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the prevention and treatment of muscular atrophy, pharmaceutical preparations for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, muscular dystrophy, sickle cell disease, and anemia, pharmaceutical preparations for the prevention and treatment of allergies, hypertension, menopause, diabetic neuropathy, arthritis, and pain, and pharmaceutical preparations for the treatment of oncological and ophthalmological diseases and disorders; pharmaceutical preparations for use in haematology for stimulating white blood cell production, for treatment of anemia, for treatment of low platelet count and bleeding disorders; pharmaceutical preparations for treatment of dermatological diseases and disorders, namely, Psoriasis, chronic blistering and skin cancer


Classification kind code

11

Mark Details


Serial Number

1806713

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 2th Nov 2018
Allowed
Submitted for opposition 51
on 2th Nov 2018
Allowance Notice Sent
Submitted for opposition 42
on 18th Jul 2018
Advertised
Submitted for opposition 26
on 28th Jun 2018
Approved
Submitted for opposition 27
on 11th May 2018
Approval Notice Sent
Submitted for opposition 22
on 15th Sept 2017
Search Recorded
Submitted for opposition 20
on 15th Sept 2017
Examiner's First Report
Submitted for opposition 31
on 31st Oct 2016
Formalized
Submitted for opposition 1
on 28th Oct 2016
Created
Submitted for opposition 30
on 27th Oct 2016
Filed